New Report Study Small interfering RNA (siRNA) Therapeutics Competitive Landscape, Technology and Pipeline Insights, 2016

The Report, “Small interfering RNA (siRNA) Therapeutics-Competitive Landscape, Technology and Pipeline Insights, 2016″ depicts the current pipeline scenario of siRNA therapies under development. Many targets which were difficult to reach by traditional small-molecule and protein have been identified by therapeutics based on RNA interference (RNAi). RNA interference (RNAi), a process in recovery Phase, is still keeping the expectations of the many mid Pharma companies at a higher end with blockbuster deals and adequate delivery technologies. 

This report analysis the current frontrunners in siRNA therapies with leading technologies and major acquisitions and deals seen in past 3 years. Report highlights the 16 different types of technologies that have been used lately to enhance the siRNA development in different stages of development. 

Get Free Sample Copy of Report - http://www.reportsweb.com/inquiry&RW0001153597/sample

There are 15+ active companies dealing with 85+ siRNA therapies. Mostly siRNA is being studied for oncology area with 27 siRNA therapies under development by major pharma companies followed by 14 therapies for infectious diseases and 8 siRNA therapies in Ophthalmology. Currently 23 siRNA are in clinical stage of development with many mid-stage products. 

Report Scope:

-Coverage of global siRNA therapies under development across the globe 
-Competitive landscape of investigational products for key players and key therapy areas
-The new siRNA report includes emerging technologies, drivers, barriers and eminent therapy areas focused by major companies.
-Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information.
-Report has highlighted the major collaborations, deals and acquisitions done by pharma companies to enrich their siRNA pipeline. 
-Report analyzes the different emerging delivery technologies by companies and products under development.

Reason to Buy:

-The siRNA report covers complete Pipeline intelligence and understanding over therapeutics development for siRNA. 
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
-Identify and understand important and diverse types of therapeutics under development for siRNA 
-The siRNA report helps to develop a better understanding of the emerging technologies by the recent acquisitions which are driving the siRNA market 
-Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
-Devise corrective measures for pipeline projects by understanding siRNA pipeline in-depth
-Identifying the upcoming leaders in the siRNA market in the coming year

Inquire to Purchase this Report - http://www.reportsweb.com/inquiry&RW0001153597/buying

Key Points from Table of Content

Executive Summary
Small interfering RNA (siRNA) Therapeutics Overview
Introduction
Historical Development:
siRNA: Mode of Action
siRNA Technology &Delivery methods
SiRNA & its Applications in Gene Silencing:
Commercial Assessment
Drivers:
Barriers:
siRNA Therapeutics: Technology Analysis
siRNA Technology & Companies Current Scenario
Companies & Technologies
siRNA Technologies & Products
siRNA Therapeutics: Collaborations Analysis
siRNA Theraputics Collaborations & Deals
siRNA Therapeutics Licensing Deals:
siRNA Therapeutics Acquisition Deals
siRNA Therapeutics: Pipeline Analysis
siRNA Theraputics Therapy Area Analysis
siRNA Therpeutics Clinical Trials Analysis
siRNA Therapeutics &USFDA/EMA Designations
Pipeline Overview
Last Stage Products (Phase III)
Comparative Analysis
Mid Stage Products (Phase II)
Comparative Analysis
Early Stage Products (Phase I and IND)
Comparative Analysis
Pre-Clinical and Discovery Products
Comparative Analysis
Therapeutic Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Discontinued Products
Dormant Products
Companies involved in Therapeutics Development
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us
Disclaimer

Read Report with Complete TOC - http://www.reportsweb.com/small-interfering-rna-sirna-therapeutics-competitive-landscape-technology-and-pipeline-insights-2016

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us: 
Call: +1-646-491-9876
Email: [email protected]